Back to mobile site

Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)

August 21, 2024 6:52 AM EDT Send to a Friend
Goldman Sachs analyst David Roman reiterated a Sell rating and $82.00 price target on Medtronic, Inc. (NYSE: MDT)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login